Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells

• Published in: The Journal of biological chemistry 2000-02, Vol.275 (5), p.3179-3191
• Main Authors: Bezzine, S, Koduri, R S, Valentin, E, Murakami, M, Kudo, I, Ghomashchi, F, Sadilek, M, Lambeau, G, Gelb, M H
• Format: Article
• Language: English
• Subjects: Animals; Arachidonic Acid - metabolism; Cell Adhesion; CHO Cells; Cricetinae; Group II Phospholipases A2; Humans; Isoenzymes - metabolism; Mice; Phospholipases A - metabolism; Protein Binding; Rats; Substrate Specificity
• ISSN: 0021-9258
• DOI: 10.1074/jbc.275.5.3179

Mammalian secreted phospholipases A(2) (sPLA2s) comprise a group of at least eight enzymes, including the recently identified group X sPLA2. A bacterial expression system was developed to produce human group X sPLA2 (hGX). Inhibition studies show that the sPLA2 inhibitor LY311727 binds modestly more tightly to human group IIA sPLA2 than to hGX and that a pyrazole-based inhibitor of group IIA sPLA2 is much less active against hGX. The phospholipid head group preference of vesicle-bound hGX was determined. hGX binds tightly to phosphatidylcholine vesicles, which is thought to be required to act efficiently on cells. Tryptophan 67 hGX makes a significant contribution to interfacial binding to zwitterionic vesicles. As little as 10 ng/ml hGX releases arachidonic acid for cyclooxygenase-2- dependent prostaglandin E(2) generation when added exogenously to adherent mammalian cells. In contrast, human group IIA, rat group V, and mouse group IB sPLA2s are virtually inactive at releasing arachidonate when added exogenously to adherent cells. Dislodging cells from the growth surface enhances the ability of all the sPLA2s to release fatty acids. Studies with CHO-K1 cell mutants show that binding of sPLA2s to glycosaminoglycans is not the basis for poor plasma membrane hydrolysis by group IB, IIA, and V sPLA2s.